Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease
Varman T. Samuel, … , Sanjay Bhanot, Gerald I. Shulman
Varman T. Samuel, … , Sanjay Bhanot, Gerald I. Shulman
Published March 1, 2007
Citation Information: J Clin Invest. 2007;117(3):739-745. https://doi.org/10.1172/JCI30400.
View: Text | PDF
Research Article Metabolism Article has an altmetric score of 10

Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease

  • Text
  • PDF
Abstract

Nonalcoholic fatty liver disease is strongly associated with hepatic insulin resistance and type 2 diabetes mellitus, but the molecular signals linking hepatic fat accumulation to hepatic insulin resistance are unknown. Three days of high-fat feeding in rats results specifically in hepatic steatosis and hepatic insulin resistance. In this setting, PKCε, but not other isoforms of PKC, is activated. To determine whether PKCε plays a causal role in the pathogenesis of hepatic insulin resistance, we treated rats with an antisense oligonucleotide against PKCε and subjected them to 3 days of high-fat feeding. Knocking down PKCε expression protects rats from fat-induced hepatic insulin resistance and reverses fat-induced defects in hepatic insulin signaling. Furthermore, we show that PKCε associates with the insulin receptor in vivo and impairs insulin receptor kinase activity both in vivo and in vitro. These data support the hypothesis that PKCε plays a critical role in mediating fat-induced hepatic insulin resistance and represents a novel therapeutic target for type 2 diabetes.

Authors

Varman T. Samuel, Zhen-Xiang Liu, Amy Wang, Sara A. Beddow, John G. Geisler, Mario Kahn, Xian-man Zhang, Brett P. Monia, Sanjay Bhanot, Gerald I. Shulman

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 1 14 7 13 7 15 12 18 12 18 11 16 17 17 22 18 20 9 8 255
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (255)

Title and authors Publication Year
Plasma Lipid Metabolites, Clinical Glycemic Predictors, and Incident Type 2 Diabetes
Begzati A, Godinez-Macias KP, Long T, Watrous JD, Moranchel R, Kantz ED, Tuomilehto J, Havulinna AS, Niiranen TJ, Jousilahti P, Salomaa V, Yu B, Norby F, Rebholz CM, Selvin E, Winzeler EA, Cheng S, Alotaibi M, Goyal R, Ideker T, Jain M, Majithia AR
Diabetes Care 2025
Changes in Cells Associated with Insulin Resistance
Szablewski L
International journal of molecular sciences 2024
The mTORC2 signaling network: targets and cross-talks
Ragupathi A, Kim C, Jacinto E
Biochemical Journal 2024
Liver Androgen Receptor Knockout Improved High-fat Diet Induced Glucose Dysregulation in Female Mice But Not Male Mice
Osei-Ntansah A, Oliver T, Lofton T, Falzarano C, Carr K, Huang R, Wilson A, Damaser E, Harvey G, Rahman MA, Andrisse S
Journal of the Endocrine Society 2024
Bridging Metabolic-Associated Steatotic Liver Disease and Cardiovascular Risk: A Potential Role for Ketogenesis
del Villar-Carrero RS, Blanco A, Ruiz LD, García-Blanco MJ, Segovia RC, de la Garza RG, Martínez-Urbistondo D
Biomedicines 2024
Mechanisms Leading to Increased Insulin-Stimulated Cerebral Glucose Uptake in Obesity and Insulin Resistance: A High-Fat Diet and Exercise Training Intervention PET Study with Rats (CROSRAT)
Jalo A, Helin JS, Hentilä J, Nissinen TA, Honkala SM, Heiskanen MA, Löyttyniemi E, Malm T, Hannukainen JC
Journal of Functional Morphology and Kinesiology 2024
John Yudkin’s hypothesis: sugar is a major dietary culprit in the development of cardiovascular disease
Ting KK
Frontiers in Nutrition 2024
Epoxygenase Cyp2c44 Regulates Hepatic Lipid Metabolism and Insulin Signaling by Controlling FATP2 Localization and Activation of the DAG/PKCδ Axis
Ghoshal K, Luther JM, Pakala SB, Chetyrkin S, Falck JR, Zent R, Wasserman DH, Pozzi A
Diabetes 2024
Risk Factors for Non-Alcoholic Fatty Liver Disease in Patients with Bipolar Disorder: A Cross-Sectional Retrospective Study.
Wang Y, Li X, Gao Y, Zhang X, Liu Y, Wu Q
Diabetes, metabolic syndrome and obesity : targets and therapy 2024
Aerobic Exercise Prevents High-Fat-Diet-Induced Adipose Tissue Dysfunction in Male Mice.
Guo Q, Li N, Shi H, Gan Y, Wang W, Jia J, Zhou Y
Nutrients 2024
Gut Microbiota and Insulin Resistance: Understanding the Mechanism of Better Treatment of Type 2 Diabetes Mellitus.
Al-Busaidi A, Alabri O, Alomairi J, ElSharaawy A, Al Lawati A, Al Lawati H, Das S
Current diabetes reviews 2024
Association Between Ultraprocessed Food Consumption and Metabolic Disorders in Children and Adolescents with Obesity
Lee GY, Lim JH, Joung H, Yoon D
Nutrients 2024
High-fat-diet-induced hepatic insulin resistance per se attenuates murine de novo lipogenesis
Goedeke L, Strober JW, Suh R, Paolella LM, Li X, Rogers JC, Petersen MC, Nasiri AR, Casals G, Kahn M, Cline GW, Samuel VT, Shulman GI, Vatner DF
iScience 2024
Physiological and pathophysiological actions of insulin in the liver
Kubota N, Kubota T, Kadowaki T
Endocrine Journal 2024
Effects of Tinospora cordifolia (giloy) on metabolic syndrome components: a mechanistic review.
Mansouri M, Imenshahidi M, Rameshrad M, Hosseinzadeh H
Naunyn-Schmiedeberg's archives of pharmacology 2024
Clinical Relevance of lncRNA and Mitochondrial Targeted Antioxidants as Therapeutic Options in Regulating Oxidative Stress and Mitochondrial Function in Vascular Complications of Diabetes
Pant T, Uche N, Juric M, Bosnjak ZJ
Antioxidants 2023
Insights into the development of insulin resistance: Unraveling the interaction of physical inactivity, lipid metabolism and mitochondrial biology
Handy RM, Holloway GP
Frontiers in physiology 2023
Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
Bhat N, Mani A
Nutrients 2023
Pathophysiology of obesity and its associated diseases
Jin X, Qiu T, Li L, Yu R, Chen X, Li C, Proud CG, Jiang T
Acta pharmaceutica Sinica. B 2023
The role of TRIM family in metabolic associated fatty liver disease
Zhang J, Zhang Y, Ren Z, Yan D, Li G
Frontiers in Endocrinology 2023
Effect of herbal extracts and Saroglitazar on high-fat diet-induced obesity, insulin resistance, dyslipidemia, and hepatic lipidome in C57BL/6J mice
Kumari D, Gautam J, Sharma V, Gupta SK, Sarkar S, Jana P, Singhal V, Babele P, Kamboj P, Bajpai S, Tandon R, Kumar Y, Dikshit M
Heliyon 2023
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)
Syed-Abdul MM
Metabolites 2023
Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice
Neha Bhat, Anand Narayanan, Mohsen Fathzadeh, Mario Kahn, Dongyan Zhang, Leigh Goedeke, Arpita Neogi, Rebecca L Cardone, Richard G Kibbey, Carlos Fernandez-Hernando, Henry N Ginsberg, Dhanpat Jain, Gerald Shulman, Arya Mani
Journal of Clinical Investigation 2022
Molecular Mechanism of Lipotoxicity as an Interesting Aspect in the Development of Pathological States—Current View of Knowledge
K Lipke, A Kubis-Kubiak, A Piwowar
Cells 2022
Insulin Resistance: From Mechanisms to Therapeutic Strategies
S Lee, S Park, C Choi
Diabetes & Metabolism Journal 2022
Sex‐ and strain‐specific effects of mitochondrial uncoupling on age‐related metabolic diseases in high‐fat diet‐fed mice
L Goedeke, K Murt, A Francesco, J Camporez, A Nasiri, Y Wang, X Zhang, G Cline, R de Cabo, G Shulman
Aging Cell 2022
Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy
M Zhao, H Wei, C Li, R Zhan, C Liu, J Gao, Y Yi, X Cui, W Shan, L Ji, B Pan, S Cheng, M Song, H Sun, H Jiang, J Cai, M Garcia-Barrio, Y Chen, X Meng, E Dong, D Wang, L Zheng
Nature Communications 2022
Bioactive lipids and metabolic syndrome—a symposium report
DeVito LM, Dennis EA, Kahn BB, Shulman GI, Witztum JL, Sadhu S, Nickels J, Spite M, Smyth S, Spiegel S
Annals of the New York Academy of Sciences 2022
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H
Signal Transduction and Targeted Therapy 2022
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction.
Mocciaro G, Gastaldelli A
Handbook of experimental pharmacology 2022
Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease.
Yin H, Shi A, Wu J
Diabetes, metabolic syndrome and obesity : targets and therapy 2022
Regulation of age-associated insulin resistance by MT1-MMP-mediated cleavage of insulin receptor.
Guo X, Asthana P, Gurung S, Zhang S, Wong SKK, Fallah S, Chow CFW, Che S, Zhai L, Wang Z, Ge X, Jiang Z, Wu J, Zhang Y, Wu X, Xu K, Lin CY, Kwan HY, Lyu A, Zhou Z, Bian ZX, Wong HLX
Nature Communications 2022
Advancements in MAFLD Modeling with Human Cell and Organoid Models
Wang SX, Yan JS, Chan YS
International journal of molecular sciences 2022
Polysaccharides influence human health via microbiota-dependent and -independent pathways
Gan L, Wang J, Guo Y
Frontiers in Nutrition 2022
Integration of Lipidomics and Transcriptomics Reveals the Efficacy and Mechanism of Qige Decoction on NAFLD
Fan S, Zhou Z, Ye J, Li Y, Huang K, Ke X
Evidence-based complementary and alternative medicine : eCAM 2022
Short-term overnutrition induces white adipose tissue insulin resistance through sn-1,2-diacylglycerol – PKCε – insulin receptorT1160 phosphorylation
Kun Lyu, Dongyan Zhang, Joongyu D. Song, Xiruo Li, Rachel J. Perry, Varman T. Samuel, Gerald I. Shulman
JCI Insight 2021
Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1
AJ Lutkewitte, JM Singer, TM Shew, MR Martino, AM Hall, M He, BN Finck
Molecular Metabolism 2021
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
H Yki-Järvinen, PK Luukkonen, L Hodson, JB Moore
Nature Reviews Gastroenterology & Hepatology 2021
Macronutrient Determinants of Obesity, Insulin Resistance and Metabolic Health
JA Wali, SM Solon-Biet, T Freire, AE Brandon
Biology : open access journal 2021
Linking biomarkers of oxidative stress and disease with flavonoid consumption: from experimental models to humans
PI Oteiza, CG Fraga, M Galleano
Redox Biology 2021
Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective
MS Ramadan, V Russo, G Nigro, E Durante-Mangoni, R Zampino
Journal of Clinical Medicine 2021
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
M Biagioli, S Fiorucci
Liver Research 2021
Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance
F He, Y Huang, Z Song, HJ Zhou, H Zhang, RJ Perry, GI Shulman, W Min
Journal of Experimental Medicine 2020
Assessment of the role of FGF15 in mediating the metabolic outcomes of murine Vertical Sleeve Gastrectomy (VSG)
A Myronovych, J Bhattacharjee, RM Salazar-Gonzalez, B Tan, S Mowery, D Ferguson, KK Ryan, W Zhang, X Zhao, M Oehrle, KennethSetchell, RJ Seeley, DA Sandoval, R Kohli
AJP Gastrointestinal and Liver Physiology 2020
Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review
K Kolczynska, A Loza-Valdes, I Hawro, G Sumara
Lipids in Health and Disease 2020
A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes
TM Batista, AK Jayavelu, NJ Albrechtsen, S Iovino, J Lebastchi, H Pan, JM Dreyfuss, A Krook, JR Zierath, M Mann, CR Kahn
Cell Metabolism 2020
Lemon Balm Extract ALS-L1023 Regulates Obesity and Improves Insulin Sensitivity via Activation of Hepatic PPARα in High-Fat Diet-Fed Obese C57BL/6J Mice
D Lee, Y Shin, JS Roh, J Ahn, S Jeoong, SS Shin, M Yoon
International journal of molecular sciences 2020
Genetic determinants of obesity heterogeneity in type II diabetes
SA Khorami, MS Mutalib, MF Shiraz, JA Abdullah, Z Rejali, RM Ali, H Khazaai
Nutrition & Metabolism 2020
A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance
K Lyu, Y Zhang, D Zhang, M Kahn, KW ter Horst, MR Rodrigues, RC Gaspar, SM Hirabara, PK Luukkonen, S Lee, S Bhanot, J Rinehart, N Blume, MG Rasch, MJ Serlie, JS Bogan, GW Cline, VT Samuel, GI Shulman
Cell Metabolism 2020
Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
X Li, D Zhang, DF Vatner, L Goedeke, SM Hirabara, Y Zhang, RJ Perry, GI Shulman
Proceedings of the National Academy of Sciences 2020
Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
KW ter Horst, DF Vatner, D Zhang, GW Cline, MT Ackermans, AJ Nederveen, J Verheij, A Demirkiran, BA van Wagensveld, GM Dallinga-Thie, M Nieuwdorp, JA Romijn, GI Shulman, MJ Serlie
Diabetes care 2020
Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications
P Sangwung, KF Petersen, GI Shulman, JW Knowles
Endocrinology 2020
Mitochondrial Dysfunction in Obesity and Reproduction
M Das, C Sauceda, NJ Webster
Endocrinology 2020
Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes
JH Yung, A Giacca
Cells 2020
The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD
C Östlund, A Hernandez-Ono, JY Shin
Biology : open access journal 2020
Cardio-Metabolic Effects of High-Fat Diets and Their Underlying Mechanisms—A Narrative Review
JA Wali, N Jarzebska, D Raubenheimer, SJ Simpson, RN Rodionov, JF OSullivan
Nutrients 2020
Effects of fructose restriction on liver steatosis (FRUITLESS); a double-blind randomized controlled trial
N Simons, P Veeraiah, PI Simons, NC Schaper, ME Kooi, VB Schrauwen-Hinderling, EJ Feskens, EM van der Ploeg, MD den Eynde, CG Schalkwijk, CD Stehouwer, MC Brouwers
The American journal of clinical nutrition 2020
The integrative biology of type 2 diabetes
M Roden, GI Shulman
Nature 2019
Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes
A Sargsyan, MA Herman
Current Diabetes Reports 2019
Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
M Longo, F Zatterale, J Naderi, L Parrillo, P Formisano, GA Raciti, F Beguinot, C Miele
International journal of molecular sciences 2019
Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes
L Goedeke, RJ Perry, GI Shulman
Annual Review of Pharmacology and Toxicology 2019
Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
DH Akhtar, U Iqbal, LM Vazquez-Montesino, BB Dennis, A Ahmed
Journal of Clinical and Translational Hepatology 2019
Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases
RO, MG, Aguilera, PD
International journal of molecular sciences 2019
Distinct Hepatic PKA and CDK Signaling Pathways Control Activity-Independent Pyruvate Kinase Phosphorylation and Hepatic Glucose Production
BM Gassaway, RL Cardone, AK Padyana, MC Petersen, ET Judd, S Hayes, S Tong, KW Barber, M Apostolidi, A Abulizi, JB Sheetz, Kshitiz, HR Aerni, S Gross, C Kung, VT Samuel, GI Shulman, RG Kibbey, J Rinehart
Cell Reports 2019
The kinase PKD3 provides negative feedback on cholesterol and triglyceride synthesis by suppressing insulin signaling
AE Mayer, MC Löffler, AE Valdés, W Schmitz, R El-Merahbi, JT Viera, M Erk, T Zhang, U Braun, M Heikenwalder, M Leitges, A Schulze, G Sumara
Science signaling 2019
Allomyrina dichotoma Larva Extract Ameliorates the Hepatic Insulin Resistance of High-Fat Diet-Induced Diabetic Mice
K Kim, GD Bae, M Lee, EY Park, DJ Baek, CY Kim, HS Jun, YS Oh
Nutrients 2019
2,4 Dinitrophenol as Medicine
J Geisler
Cells 2019
Hepatic miR‑215 target Rictor and modulation of hepatic insulin signalling in rats
WD Li, JR Xia, YS Lian
Molecular medicine reports 2019
Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
N DaliYoucef, , F Costantino, H ElSaghire, B Lhermitte, C Callari, J DAgostino, S Perretta, S Paveliu, M Gualtierotti, E Dumeny, MA Oudot, A Jaulin, D Dembélé, MB Zeisel, C Tomasetto, TF Baumert, M Doffoël
Hepatology Communications 2019
The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity
J Bricambert, MC Alves-Guerra, P Esteves, C Prip-Buus, J Bertrand-Michel, H Guillou, CJ Chang, MN Wal, F Canonne-Hergaux, P Mathurin, V Raverdy, F Pattou, J Girard, C Postic, R Dentin
Nature Communications 2018
Mechanisms of Insulin Action and Insulin Resistance
MC Petersen, GI Shulman
Physiological reviews 2018
Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation
RJ Perry, Y Wang, GW Cline, A Rabin-Court, JD Song, S Dufour, XM Zhang, KF Petersen, GI Shulman
Cell 2018
Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes
RJ Perry, L Peng, GW Cline, Y Wang, A Rabin-Court, JD Song, D Zhang, XM Zhang, Y Nozaki, S Dufour, KF Petersen, GI Shulman
Cell Metabolism 2018
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents
DF Vatner, L Goedeke, JP Camporez, K Lyu, AR Nasiri, D Zhang, S Bhanot, SF Murray, CD Still, GS Gerhard, GI Shulman, VT Samuel
Diabetologia 2018
Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption
FW Sanders, A Acharjee, C Walker, L Marney, LD Roberts, F Imamura, B Jenkins, J Case, S Ray, S Virtue, A Vidal-Puig, D Kuh, R Hardy, M Allison, N Forouhi, AJ Murray, N Wareham, M Vacca, A Koulman, JL Griffin
Genome biology 2018
Metabolites as regulators of insulin sensitivity and metabolism
Q Yang, A Vijayakumar, BB Kahn
Nature Reviews Molecular Cell Biology 2018
PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed Rats
SA Beddow, AK Gattu, DF Vatner, L Paolella, A Alqarzaee, N Tashkandi, VB Popov, CD Church, MS Rodeheffer, GW Cline, JG Geisler, S Bhanot, VT Samuel
Endocrinology 2018
Implementation of environmental enrichment after middle age promotes healthy aging
T McMurphy, W Huang, NJ Queen, S Ali, KJ Widstrom, X Liu, R Xiao, JJ Siu, L Cao
Aging 2018
DNA methylation in the pathogenesis of type 2 diabetes in humans
C Davegårdh, S García-Calzón, K Bacos, C Ling
Molecular Metabolism 2018
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
DH Ipsen, J Lykkesfeldt, P Tveden-Nyborg
Cellular and Molecular Life Sciences 2018
The effect of high fat diet and metformin treatment on liver lipids accumulation and their impact on insulin action
P Zabielski, HR Hady, M Chacinska, K Roszczyc, J Gorski, AU Blachnio-Zabielska
Scientific Reports 2018
Angiotensin II type 2 receptor inhibits expression and function of insulin receptor in rat renal proximal tubule cells
Y Yang, C Chen, C Fu, Z Xu, C Lan, Y Zeng, Z Chen, PA Jose, Y Zhang, C Zeng
Journal of the American Society of Hypertension : JASH 2018
Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation
C Wang, Y Li, M Hao, W Li
Frontiers in pharmacology 2018
Identification of Protein Kinase C Isoforms Involved in Type 1 Diabetic Encephalopathy in Mice
J Zheng, Y Wang, S Han, Y Luo, X Sun, N Zhu, L Zhao, J Li
Journal of Diabetes Research 2018
PKCε contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling
BM Gassaway, MC Petersen, YV Surovtseva, KW Barber, JB Sheetz, HR Aerni, JS Merkel, VT Samuel, GI Shulman, J Rinehart
Proceedings of the National Academy of Sciences 2018
Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review
P Bjornstad, RH Eckel
Current Diabetes Reports 2018
Cardiac metabolic effects of K Na 1.2 channel deletion and evidence for its mitochondrial localization
CO Smith, YT Wang, SM Nadtochiy, JH Miller, EA Jonas, RT Dirksen, K Nehrke, PS Brookes
The FASEB Journal 2018
Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
T Jelenik, K Kaul, G Séquaris, U Flögel, E Phielix, J Kotzka, B Knebel, P Fahlbusch, T Hörbelt, S Lehr, AL Reinbeck, D Müller-Wieland, I Esposito, GI Shulman, J Szendroedi, M Roden
Diabetes 2017
Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
KW Horst, PW Gilijamse, RI Versteeg, MT Ackermans, AJ Nederveen, SE la Fleur, JA Romijn, M Nieuwdorp, D Zhang, VT Samuel, DF Vatner, KF Petersen, GI Shulman, MJ Serlie
Cell Reports 2017
Regulation of hepatic glucose metabolism in health and disease
MC Petersen, DF Vatner, GI Shulman
Nature Reviews Endocrinology 2017
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
VT Samuel, GI Shulman
Cell Metabolism 2017
Mechanism by which arylamine N -acetyltransferase 1 ablation causes insulin resistance in mice
JP Camporez, Y Wang, K Faarkrog, N Chukijrungroat, KF Petersen, GI Shulman
Proceedings of the National Academy of Sciences 2017
IRS posttranslational modifications in regulating insulin signaling
J Peng, L He
Journal of Molecular Endocrinology 2017
Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
MC Petersen, GI Shulman
Trends in Pharmacological Sciences 2017
Biochemical and cellular properties of insulin receptor signalling
RA Haeusler, TE McGraw, D Accili
Nature Reviews Molecular Cell Biology 2017
A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice
A Abulizi, RJ Perry, JP Camporez, MJ Jurczak, KF Petersen, P Aspichueta, GI Shulman
The FASEB Journal 2017
The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
F Perla, M Prelati, M Lavorato, D Visicchio, C Anania
Children 2017
PKCδ silencing alleviates saturated fatty acid induced ER stress by enhancing SERCA activity
S Lai, Y Li, Y Kuang, H Cui, Y Yang, W Sun, K Liu, D Chen, Q Yan, L Wen
Bioscience Reports 2017
Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.
Ter Horst KW, Serlie MJ
Nutrients 2017
Insulin Receptor Thr1160 Phosphorylation Mediates Lipid-Induced Hepatic Insulin Resistance
Max Petersen, Anila K. Madiraju, Brandon Gassaway, Michael Marcel, Ali Nasiri, Gina Butrico, Melissa Marcucci, Dongyan Zhang, Abudukadier Abulizi, Xian-Man Zhang, William Philbrick, stevan Hubbard, Michael J. Jurczak, Varman Samuel, Jesse Rinehart, Gerald I. Shulman
Journal of Clinical Investigation 2016
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Varman Samuel, Gerald I. Shulman
Journal of Clinical Investigation 2016
Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
H Kirchner, I Sinha, H Gao, MA Ruby, M Schönke, JM Lindvall, R Barrès, A Krook, E Näslund, K Dahlman-Wright, JR Zierath
Molecular Metabolism 2016
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
S Ballestri, F Nascimbeni, D Romagnoli, E Baldelli, G Targher, A Lonardo
International journal of molecular sciences 2016
Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance
KC Nandipati, S Subramanian, DK Agrawal
Molecular and Cellular Biochemistry 2016
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
CG Wilson, JL Tran, DM Erion, NB Vera, M Febbraio, EJ Weiss
Endocrinology 2016
Mechanisms of intrahepatic triglyceride accumulation
C Ress
World journal of gastroenterology : WJG 2016
Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver�disease and hepatic insulin resistance through the regulation of�peroxisome proliferator-activated receptor γ
S Tsujimoto, M Kishina, M Koda, Y Yamamoto, K Tanaka, Y Harada, A Yoshida, I Hisatome
International journal of molecular medicine 2016
11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes
K Peng, Y Pan, J Li, Z Khan, M Fan, H Yin, C Tong, Y Zhao, G Liang, C Zheng
Scientific Reports 2016
The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis
MA Herman, VT Samuel
Trends in Endocrinology & Metabolism 2016
Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment
ME Ertunc, GS Hotamisligil
Journal of lipid research 2016
Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome
S Ussar, S Fujisaka, CR Kahn
Molecular Metabolism 2016
XBP1s Is an Anti-lipogenic Protein
H Herrema, Y Zhou, D Zhang, J Lee, MA Hernandez, GI Shulman, U Ozcan
The Journal of biological chemistry 2016
Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance
L Wang, B Zhang, F Huang, B Liu, Y Xie
Journal of lipid research 2016
Flavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated Hepatocytes
BM Liao, SA McManus, WE Hughes, C Schmitz-Peiffer
Molecular Endocrinology 2016
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels
A Nagarajan, MC Petersen, AR Nasiri, G Butrico, A Fung, HB Ruan, R Kursawe, S Caprio, J Thibodeau, MC Bourgeois-Daigneault, L Sun, G Gao, S Bhanot, MJ Jurczak, MR Green, GI Shulman, N Wajapeyee
Nature Communications 2016
(-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice
E Cremonini, A Bettaieb, FG Haj, CG Fraga, PI Oteiza
Archives of Biochemistry and Biophysics 2016
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
P Wainwright, C Byrne
International journal of molecular sciences 2016
Hepatic Steatosis as a Marker of Metabolic Dysfunction
E Fabbrini, F Magkos
Nutrients 2015
Sexual Dimorphism in Hepatic, Adipose Tissue, and Peripheral Tissue Insulin Sensitivity in Obese Humans
KW Horst, PW Gilijamse, BA de Weijer, M Kilicarslan, MT Ackermans, AJ Nederveen, M Nieuwdorp, JA Romijn, MJ Serlie
Frontiers in Endocrinology 2015
Dietary approach in the treatment of nonalcoholic fatty liver disease
SM Ferolla
World journal of hepatology 2015
Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
JC Correia, J Massart, JF de Boer, M Porsmyr-Palmertz, V Martínez-Redondo, LZ Agudelo, I Sinha, D Meierhofer, V Ribeiro, M Björnholm, S Sauer, K Dahlman-Wright, JR Zierath, AK Groen, JL Ruas
Molecular Metabolism 2015
OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease
TE Akie, L Liu, M Nam, S Lei, MP Cooper, P Aspichueta
PloS one 2015
Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?
BN Finck, AM Hall
BioMed Research International 2015
Second-generation antisense oligonucleotides against  -catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance
VB Popov, FR Jornayvaz, EO Akgul, S Kanda, MJ Jurczak, D Zhang, A Abudukadier, SK Majumdar, B Guigni, KF Petersen, VP Manchem, S Bhanot, GI Shulman, VT Samuel
The FASEB Journal 2015
Lipid-mediated muscle insulin resistance: different fat, different pathways?
O Ritter, T Jelenik, M Roden
Journal of Molecular Medicine 2015
DAG tales: the multiple faces of diacylglycerol—stereochemistry, metabolism, and signaling
TO Eichmann, A Lass
Cellular and Molecular Life Sciences 2015
Intravenous Mycobacterium Bovis Bacillus Calmette-Guérin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice
M Inafuku, G Matsuzaki, H Oku, M Makishima
PloS one 2015
3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats
DF Vatner, J Snikeris, V Popov, RJ Perry, Y Rahimi, VT Samuel, C Moro
PloS one 2015
FFA-induced hepatic insulin resistance in vivo is mediated by PKC , NADPH oxidase, and oxidative stress
S Pereira, E Park, Y Mori, CA Haber, P Han, T Uchida, L Stavar, AI Oprescu, K Koulajian, A Ivovic, Z Yu, D Li, TA Bowman, J Dewald, J El-Benna, DN Brindley, R Gutierrez-Juarez, TK Lam, SM Najjar, RA McKay, S Bhanot, IG Fantus, A Giacca
American journal of physiology. Endocrinology and metabolism 2014
A Role for Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) in the Regulation of Hepatic Gluconeogenesis
R Stark, F Guebre-Egziabher, X Zhao, C Feriod, J Dong, TC Alves, S Ioja, RL Pongratz, S Bhanot, M Roden, GW Cline, GI Shulman, RG Kibbey
The Journal of biological chemistry 2014
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes
AL Birkenfeld, GI Shulman
Hepatology 2014
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
RJ Perry, VT Samuel, KF Petersen, GI Shulman
Nature 2014
Insulin Receptor Signaling in Normal and Insulin-Resistant States
J Boucher, A Kleinridders, CR Kahn
Cold Spring Harbor perspectives in biology 2014
Effect of diacylglycerol acyltransferase 2 overexpression in 3T3-L1 is associated to an increase in mono-unsaturated fatty acid accumulation
Z Zhang, G Shu, X Zhu, J Guo, H Cai, S Wang, L Wang, P Gao, Q Xi, Y Zhang, L Yuan, Q Jiang
Journal of Animal Science and Biotechnology 2014
Defect of insulin signal in peripheral tissues: Important role of ceramide
RH Hassan, O Bourron, E Hajduch
World journal of diabetes 2014
Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population
MR Li
World journal of gastroenterology : WJG 2014
Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance
Y Rahimi, JP Camporez, MC Petersen, D Pesta, RJ Perry, MJ Jurczak, GW Cline, GI Shulman
Proceedings of the National Academy of Sciences 2014
(−)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress
A Bettaieb, MA Prieto, CR Lanzi, RM Miatello, FG Haj, CG Fraga, PI Oteiza
Free radical biology & medicine 2014
Abrogating Monoacylglycerol Acyltransferase Activity in Liver Improves Glucose Tolerance and Hepatic Insulin Signaling in Obese Mice
AM Hall, N Soufi, KT Chambers, Z Chen, GG Schweitzer, KS McCommis, DM Erion, MJ Graham, X Su, BN Finck
Diabetes 2014
Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population
TH Niu, M Jiang, YN Xin, XJ Jiang, ZH Lin, SY Xuan
World journal of gastroenterology : WJG 2014
Inputs and outputs of insulin receptor
Y Du, T Wei
Protein & Cell 2014
Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
L Abenavoli
World journal of gastroenterology : WJG 2014
Targeting steroid receptor coactivator 1 with antisense oligonucleotides increases insulin-stimulated skeletal muscle glucose uptake in chow-fed and high-fat-fed male rats
JL Cantley, DF Vatner, T Galbo, A Madiraju, M Petersen, RJ Perry, N Kumashiro, F Guebre-Egziabher, AK Gattu, MR Stacy, DP Dione, AJ Sinusas, L Ragolia, CE Hall, VP Manchem, S Bhanot, JS Bogan, VT Samuel
American journal of physiology. Endocrinology and metabolism 2014
Molecular Mechanisms Underlying Fasting Modulated Liver Insulin Sensitivity and Metabolism in Male Lipodystrophic Bscl2 /Seipin-Deficient Mice
W Chen, H Zhou, P Saha, L Li, L Chan
Endocrinology 2014
Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance
N Kumashiro, SA Beddow, DF Vatner, SK Majumdar, JL Cantley, F Guebre-Egziabher, I Fat, B Guigni, MJ Jurczak, AL Birkenfeld, M Kahn, BK Perler, MA Puchowicz, VP Manchem, S Bhanot, CD Still, GS Gerhard, KF Petersen, GW Cline, GI Shulman, VT Samuel
Diabetes 2013
Duration of rise in free fatty acids determines salicylate's effect on hepatic insulin sensitivity
S Pereira, WQ Yu, ME Frigolet, JL Beaudry, Y Shpilberg, E Park, C Dirlea, BL Nyomba, MC Riddell, IG Fantus, A Giacca
Journal of Endocrinology 2013
Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect
RS Rector, EM Morris, S Ridenhour, GM Meers, FF Hsu, J Turk, JA Ibdah
Hepatology 2013
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
MD Fullerton, S Galic, K Marcinko, S Sikkema, T Pulinilkunnil, ZP Chen, HM O'Neill, RJ Ford, R Palanivel, M O'Brien, DG Hardie, SL Macaulay, JD Schertzer, JR Dyck, BJ van Denderen, BE Kemp, GR Steinberg
Nature Medicine 2013
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
DF Vatner, D Weismann, SA Beddow, N Kumashiro, DM Erion, XH Liao, GJ Grover, P Webb, KJ Phillips, RE Weiss, JS Bogan, J Baxter, GI Shulman, VT Samuel
American journal of physiology. Endocrinology and metabolism 2013
Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment
B Fruci, S Giuliano, A Mazza, R Malaguarnera, A Belfiore
International journal of molecular sciences 2013
Liver and diabetes. A vicious circle
P Loria, A Lonardo, F Anania
Hepatology Research 2013
Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo
T Galbo, RJ Perry, MJ Jurczak, JP Camporez, TC Alves, M Kahn, BA Guigni, J Serr, D Zhang, S Bhanot, VT Samuel, GI Shulman
Proceedings of the National Academy of Sciences 2013
Impaired PI3 K Akt expression in liver and skeletal muscle of ovariectomized rats
Y Wang, B Li, W Zhang, Y Liu, P Xue, J Ma, Y Li
Endocrine 2013
The Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats
DM Erion, V Popov, JJ Hsiao, D Vatner, K Mitchell, S Yonemitsu, Y Nagai, M Kahn, MP Gillum, J Dong, SF Murray, VP Manchem, S Bhanot, GW Cline, GI Shulman, VT Samuel
Endocrinology 2013
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance
JL Cantley, T Yoshimura, JP Camporez, D Zhang, FR Jornayvaz, N Kumashiro, F Guebre-Egziabher, MJ Jurczak, M Kahn, BA Guigni, J Serr, J Hankin, RC Murphy, GW Cline, S Bhanot, VP Manchem, JM Brown, VT Samuel, GI Shulman
Proceedings of the National Academy of Sciences 2013
Lipid signals and insulin resistance
C Zhang, EL Klett, RA Coleman
Clinical Lipidology 2013
The Role of INDY in Metabolic Regulation
DM Willmes, AL Birkenfeld
Computational and Structural Biotechnology Journal 2013
Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype
S Fayyaz, J Henkel, L Japtok, S Krämer, G Damm, D Seehofer, GP Püschel, B Kleuser
Diabetologia 2013
Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats
N Kumashiro, T Yoshimura, JL Cantley, SK Majumdar, F Guebre-Egziabher, R Kursawe, DF Vatner, I Fat, M Kahn, DM Erion, XM Zhang, D Zhang, VP Manchem, S Bhanot, GS Gerhard, KF Petersen, GW Cline, VT Samuel, GI Shulman
Hepatology 2013
Reversal of Hypertriglyceridemia, Fatty Liver Disease, and Insulin Resistance by a Liver-Targeted Mitochondrial Uncoupler
RJ Perry, T Kim, XM Zhang, HY Lee, D Pesta, VB Popov, D Zhang, Y Rahimi, MJ Jurczak, GW Cline, DA Spiegel, GI Shulman
Cell Metabolism 2013
Protein kinase Cε modulates insulin receptor localization and trafficking in mouse embryonic fibroblasts
DJ Pedersen, B Diakanastasis, J Stöckli, C Schmitz-Peiffer
PloS one 2013
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans
Fadila Rayah, Pierre-Damien Denechaud, Maud Lemoine, Céline Robichon, Marthe Moldes, Justine Bertrand -Michel, Vlad Ratziu, Lawrence Serfaty, Chantal Housset, Jacqueline Capeau, Jean Girard, Hervé Guillou, Catherine Postic
Journal of Clinical Investigation 2012
Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
FR Jornayvaz, GI Shulman
Cell Metabolism 2012
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
KD Copps, MF White
Diabetologia 2012
Targeted overexpression of inducible 6-phosphofructo-2-kinase in adipose tissue increases fat deposition but protects against diet-induced insulin resistance and inflammatory responses
Y Huo, X Guo, H Li, H Xu, V Halim, W Zhang, H Wang, YY Fan, KT Ong, SL Woo, RS Chapkin, DG Mashek, Y Chen, H Dong, F Lu, L Wei, C Wu
The Journal of biological chemistry 2012
The inflammation highway: metabolism accelerates inflammatory traffic in obesity
AR Johnson, JJ Milner, L Makowski
Immunological Reviews 2012
Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes
KF Petersen, S Dufour, K Morino, PS Yoo, GW Cline, GI Shulman
Proceedings of the National Academy of Sciences 2012
Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages
Z Papackova, E Palenickova, H Dankova, J Zdychova, V Skop, L Kazdova, M Cahova
Nutrition & Metabolism 2012
Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans
BC Bergman, DM Hunerdosse, A Kerege, MC Playdon, L Perreault
Diabetologia 2012
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
Z Sun, RA Miller, RT Patel, J Chen, R Dhir, H Wang, D Zhang, MJ Graham, TG Unterman, GI Shulman, C Sztalryd, MJ Bennett, RS Ahima, MJ Birnbaum, MA Lazar
Nature Medicine 2012
The Increased Activity of Liver Lysosomal Lipase in Nonalcoholic Fatty Liver Disease Contributes to the Development of Hepatic Insulin Resistance
M Cahova, H Dankova, E Palenickova, Z Papackova, R Komers, J Zdychova, E Sticova, L Kazdova
Biochemistry Research International 2012
Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice
RM Carr, RT Patel, V Rao, R Dhir, MJ Graham, RM Crooke, RS Ahima
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2012
Decreased Transcription of ChREBP- /  Isoforms in Abdominal Subcutaneous Adipose Tissue of Obese Adolescents With Prediabetes or Early Type 2 Diabetes: Associations With Insulin Resistance and Hyperglycemia
R Kursawe, S Caprio, C Giannini, D Narayan, A Lin, E D'Adamo, M Shaw, B Pierpont, SW Cushman, GI Shulman
Diabetes 2012
Foxa1 Reduces Lipid Accumulation in Human Hepatocytes and Is Down-Regulated in Nonalcoholic Fatty Liver
M Moya, M Benet, C Guzmán, L Tolosa, C García-Monzón, E Pareja, JV Castell, R Jover
PloS one 2012
Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism
WH Brown, MP Gillum, HY Lee, JP Camporez, X Zhang, JK Jeong, TC Alves, DM Erion, BA Guigni, M Kahn, VT Samuel, BF Cravatt, S Diano, GI Shulman
Proceedings of the National Academy of Sciences 2012
Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6 J mice fed a high-fat diet via fatty acid oxidation
HH Jang, MY Park, HW Kim, YM Lee, KA Hwang, JH Park, DS Park, O Kwon
Nutrition & Metabolism 2012
Novel nongenomic signaling by glucocorticoid may involve changes to liver membrane order in rainbow trout
L Dindia, J Murray, E Faught, TL Davis, Z Leonenko, MM Vijayan
PloS one 2012
E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia
EJ Dhurandhar, R Krishnapuram, V Hegde, O Dubuisson, R Tao, XC Dong, J Ye, NV Dhurandhar
PloS one 2012
PKCd Serves as a Regulator of Hepatic Insulin Sensitivity and Risk of Hepatosteatosis in Humans and Mice
Olivier Bezy, Thien T. Tran, Jussi Pihlajamäki, Ryo Suzuki, Brice Emanuelli, Jonathan Winnay, Marcelo Mori, Joel Haas, Sudha B. Biddinger, Michael Leitges, Allison Goldfine, Patti Mary Elizabeth, George King, C. Ronald Kahn
Journal of Clinical Investigation 2011
Influence of the Hepatic Eukaryotic Initiation Factor 2α (eIF2α) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose Metabolism*
AL Birkenfeld, HY Lee, S Majumdar, MJ Jurczak, JP Camporez, FR Jornayvaz, DW Frederick, B Guigni, M Kahn, D Zhang, D Weismann, AM Arafat, AF Pfeiffer, S Lieske, S Oyadomari, D Ron, VT Samuel, GI Shulman
The Journal of biological chemistry 2011
Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance
HY Lee, AL Birkenfeld, FR Jornayvaz, MJ Jurczak, S Kanda, V Popov, DW Frederick, D Zhang, B Guigni, KG Bharadwaj, CS Choi, IJ Goldberg, JH Park, KF Petersen, VT Samuel, GI Shulman
Hepatology 2011
Dissociation of Inositol-requiring Enzyme (IRE1α)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice*
MJ Jurczak, AH Lee, FR Jornayvaz, HY Lee, AL Birkenfeld, BA Guigni, M Kahn, VT Samuel, LH Glimcher, GI Shulman
The Journal of biological chemistry 2011
Time-dependent effects of Prkce deletion on glucose homeostasis and hepatic lipid metabolism on dietary lipid oversupply in mice
K Raddatz, N Turner, G Frangioudakis, BM Liao, DJ Pedersen, J Cantley, D Wilks, E Preston, BD Hegarty, M Leitges, MJ Raftery, TJ Biden, C Schmitz-Peiffer
Diabetologia 2011
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
N Kumashiro, DM Erion, D Zhang, M Kahn, SA Beddow, X Chu, CD Still, GS Gerhard, X Han, J Dziura, KF Petersen, VT Samuel, GI Shulman
Proceedings of the National Academy of Sciences 2011
The macrophage at the intersection of immunity and metabolism in obesity
MC Samaan
Diabetology & metabolic syndrome 2011
Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
JW Perfield, Y Lee, GI Shulman, VT Samuel, MJ Jurczak, E Chang, C Xie, PN Tsichlis, MS Obin, AS Greenberg
Diabetes 2011
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
ME Visser, NM Lammers, AJ Nederveen, M der Graaf, A Heerschap, MT Ackermans, HP Sauerwein, ES Stroes, MJ Serlie
Diabetologia 2011
Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
FR Jornayvaz, AL Birkenfeld, MJ Jurczak, S Kanda, BA Guigni, DC Jiang, D Zhang, HY Lee, VT Samuel, GI Shulman
Proceedings of the National Academy of Sciences 2011
Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction
DA Ghareeb, HS Hafez, HM Hussien, NF Kabapy
Metabolic Brain Disease 2011
Mammalian TOR signaling to the AGC kinases
B Su, E Jacinto
Critical Reviews in Biochemistry and Molecular Biology 2011
Deletion of the Mammalian INDY Homologue Mimics Aspects of Dietary Restriction and Protects Against Adiposity and Insulin Resistance in Mice
AL Birkenfeld, HY Lee, F Guebre-Egziabher, TC Alves, MJ Jurczak, FR Jornayvaz, D Zhang, JJ Hsiao, A Martin-Montalvo, A Fischer-Rosinsky, J Spranger, AF Pfeiffer, J Jordan, MF Fromm, J König, S Lieske, CM Carmean, DW Frederick, D Weismann, F Knauf, PM Irusta, RD Cabo, SL Helfand, VT Samuel, GI Shulman
Cell Metabolism 2011
Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins
W Qin, M Sundaram, Y Wang, H Zhou, S Zhong, CC Chang, S Manhas, EF Yao, RJ Parks, PJ McFie, SJ Stone, ZG Jiang, C Wang, D Figeys, W Jia, Z Yao
The Journal of biological chemistry 2011
Coordinated Defects in Hepatic Long Chain Fatty Acid Metabolism and Triglyceride Accumulation Contribute to Insulin Resistance in Non-Human Primates
S Kamath, AO Chavez, A Gastaldelli, F Casiraghi, GA Halff, GA Abrahamian, AM Davalli, RA Bastarrachea, AG Comuzzie, R Guardado-Mendoza, LM Jimenez-Ceja, V Mattern, AM Paez, A Ricotti, ME Tejero, PB Higgins, IP Rodriguez-Sanchez, D Tripathy, RA DeFronzo, EJ Dick, GW Cline, F Folli
PloS one 2011
Regulation of Hepatic Fat and Glucose Oxidation in Rats with Lipid-Induced Hepatic Insulin Resistance
TC Alves, DE Befroy, RG Kibbey, M Kahn, R Codella, RA Carvalho, KF Petersen, GI Shulman
Hepatology 2011
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
JE Mells, PP Fu, S Sharma, D Olson, L Cheng, JA Handy, NK Saxena, D Sorescu, FA Anania
American journal of physiology. Gastrointestinal and liver physiology 2011
Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance
FR Jornayvaz, HY Lee, MJ Jurczak, TC Alves, F Guebre-Egziabher, BA Guigni, D Zhang, VT Samuel, JE Silva, GI Shulman
Endocrinology 2011
Estrogen-related receptor γ (ERRγ) is a novel transcriptional regulator of phosphatidic acid phosphatase, LIPIN1, and inhibits hepatic insulin signaling
DK Kim, JR Kim, M Koh, YD Kim, JM Lee, D Chanda, SB Park, JJ Min, CH Lee, TS Park, HS Choi
The Journal of biological chemistry 2011
High-fat diet activates pro-inflammatory response in the prostate through association of Stat-3 and NF-κB
E Shankar, EV Vykhovanets, OV Vykhovanets, GT Maclennan, R Singh, N Bhaskaran, S Shukla, S Gupta
The Prostate 2011
Endoplasmic Reticulum Stress Promotes LIPIN2-Dependent Hepatic Insulin Resistance
D Ryu, WY Seo, YS Yoon, YN Kim, SS Kim, HJ Kim, TS Park, CS Choi, SH Koo
Diabetes 2011
Reply to Monetti et al.: Hepatic steatosis and diacylglycerol-mediated hepatic insulin resistance in acyl-CoA:diacylglycerol acyltransferase 2 (DGAT2) transgenic mice
Jornayvaz FR, Jurczak MJ, Samuel VT, Shulman GI
Proceedings of the National Academy of Sciences 2011
A Common Variant in the Patatin-Like Phospholipase 3 Gene (PNPLA3) Is Associated with Fatty Liver Disease in Obese Children and Adolescents
N Santoro, R Kursawe, E D'Adamo, DJ Dykas, CK Zhang, AE Bale, AM Calí, D Narayan, MM Shaw, B Pierpont, M Savoye, D Lartaud, S Eldrich, SW Cushman, H Zhao, GI Shulman, S Caprio
Hepatology 2010
Protein kinase Cbeta mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin
T Yamamoto, K Watanabe, N Inoue, Y Nakagawa, N Ishigaki, T Matsuzaka, Y Takeuchi, K Kobayashi, S Yatoh, A Takahashi, H Suzuki, N Yahagi, T Gotoda, N Yamada, H Shimano
Journal of lipid research 2010
The Role of Muscle Insulin Resistance in the Pathogenesis of Atherogenic Dyslipidemia and Nonalcoholic Fatty Liver Disease Associated with the Metabolic Syndrome
FR Jornayvaz, VT Samuel, GI Shulman
Annual Review of Nutrition 2010
PKCδ Is Activated in a Dietary Model of Steatohepatitis and Regulates Endoplasmic Reticulum Stress and Cell Death*
MW Greene, CM Burrington, MS Ruhoff, AK Johnson, T Chongkrairatanakul, A Kangwanpornsiri
The Journal of biological chemistry 2010
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Q Liu, S Bengmark, S Qu
Lipids in Health and Disease 2010
CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance[S]
JM Brown, JL Betters, C Lord, Y Ma, X Han, K Yang, HM Alger, J Melchior, J Sawyer, R Shah, MD Wilson, X Liu, MJ Graham, R Lee, R Crooke, GI Shulman, B Xue, H Shi, L Yu
Journal of lipid research 2010
Diacylglycerol-mediated insulin resistance
DM Erion, GI Shulman
Nature Medicine 2010
Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms
JA Chavez, SA Summers
Biochimica et Biophysica Acta 2010
Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-γ (PPAR-γ) activation in a rat model of insulin resistance
D Weismann, DM Erion, I Ignatova-Todorava, Y Nagai, R Stark, JJ Hsiao, C Flannery, AL Birkenfeld, T May, M Kahn, D Zhang, XX Yu, SF Murray, S Bhanot, BP Monia, GW Cline, GI Shulman, VT Samuel
Diabetologia 2010
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
KF Petersen, S Dufour, A Hariri, C Nelson-Williams, JN Foo, XM Zhang, J Dziura, RP Lifton, GI Shulman
The New England journal of medicine 2010
Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice
SM Turpin, AJ Hoy, RD Brown, CG Rudaz, J Honeyman, M Matzaris, MJ Watt
Diabetologia 2010
Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity
AA Wendel, LO Li, Y Li, GW Cline, GI Shulman, RA Coleman
Diabetes 2010
A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain
FR Jornayvaz, MJ Jurczak, HY Lee, AL Birkenfeld, DW Frederick, D Zhang, XM Zhang, VT Samuel, GI Shulman
American journal of physiology. Endocrinology and metabolism 2010
Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats
JW Han, XR Zhan, XY Li, B Xia, YY Wang, J Zhang, BX Li
World journal of gastroenterology : WJG 2010
Resistance to High-Fat Diet-Induced Obesity and Insulin Resistance in Mice with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
D Zhang, J Christianson, ZX Liu, L Tian, CS Choi, S Neschen, J Dong, PA Wood, GI Shulman
Cell Metabolism 2010
Fructose consumption: recent results and their potential implications
KL Stanhope, PJ Havel
Annals of the New York Academy of Sciences 2010
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study
P Dongiovanni, R Rametta, AL Fracanzani, L Benedan, V Borroni, P Maggioni, M Maggioni, S Fargion, L Valenti
BMC Gastroenterology 2010
Early Hepatic Insulin Resistance in Mice: A Metabolomics Analysis
LO Li, YF Hu, L Wang, M Mitchell, A Berger, RA Coleman
Molecular Endocrinology 2010
GRP78 inhibits SREBP-1c cleavage induced by insulin and endoplasmic reticulum stress: consequences for hepatic steatosis
Hélène L. Kammoun, Hervé Chabanon, Isabelle Hainault, Serge Luquet, Christophe Magnan, Tatsuro Koike, Pascal Ferré, Fabienne Foufelle
Journal of Clinical Investigation 2009
Effects of consuming fructose- or glucose-sweetened beverages for 10 weeks on lipids, insulin sensitivity and adiposity
Kimber L. Stanhope, Jean Marc Schwarz, Nancy L. Keim, Steven C. Griffen, Andrew A. Bremer, James L. Graham, Bonnie Hatcher, Artem Dyachenko, Wei Zhang, Chad L. Cox, John P. McGahan, Anthony Seibert, Ronald M. Krauss, Sally Chiu, Ernst J. Schaefer, Masumi Ai, Seiko Otokozawa, Katsuyuki Nakajima, Takamitsu Nakano, Carine Beysen, Marc K. Hellerstein, Lars Berglund, Peter J. Havel
Journal of Clinical Investigation 2009
Palmitic Acid mediates hypothalamic insulin resistance via Protein kinase-C (PKC) theta
Christopher J. Kemp, Stephen C. Benoit, Carol F. Elias, William Abplanalp, , James P. Herman, Stephanie Migrenne, Anne-Laure Lefevre, Céline Cruciani-Guglielmacci, Christophe Magnan, Fang Yu, Kevin Niswender, Boman G. Irani, William L. Holland, and Deborah J. Clegg
Journal of Clinical Investigation 2009
Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein
DM Erion, ID Ignatova, S Yonemitsu, Y Nagai, P Chatterjee, D Weismann, JJ Hsiao, D Zhang, T Iwasaki, R Stark, C Flannery, M Kahn, CM Carmean, XX Yu, SF Murray, S Bhanot, BP Monia, GW Cline, VT Samuel, GI Shulman
Cell Metabolism 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Molecular mechanisms involved in NAFLD progression
M Malaguarnera, MD Rosa, F Nicoletti, L Malaguarnera
Journal of Molecular Medicine 2009
The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?
L Valenti, AL Fracanzani, S Fargion
Seminars in Immunopathology 2009
Diverse roles for protein kinase C δ and protein kinase C ε in the generation of high-fat-diet-induced glucose intolerance in mice: regulation of lipogenesis by protein kinase C δ
G Frangioudakis, JG Burchfield, S Narasimhan, GJ Cooney, M Leitges, TJ Biden, C Schmitz-Peiffer
Diabetologia 2009
The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance
I Pagel-Langenickel, J Bao, L Pang, MN Sack
Endocrine reviews 2009
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats
DM Erion, S Yonemitsu, Y Nie, Y Nagai, MP Gillum, JJ Hsiao, T Iwasaki, R Stark, D Weismann, XX Yu, SF Murray, S Bhanot, BP Monia, TL Horvath, Q Gao, VT Samuel, GI Shulman
Proceedings of the National Academy of Sciences 2009
The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator-1 β in the Pathogenesis of Fructose-Induced Insulin Resistance
Y Nagai, S Yonemitsu, DM Erion, T Iwasaki, R Stark, D Weismann, J Dong, D Zhang, MJ Jurczak, MG Löffler, J Cresswell, XX Yu, SF Murray, S Bhanot, BP Monia, JS Bogan, V Samuel, GI Shulman
Cell Metabolism 2009
Exercise therapy in type 2 diabetes
SF Praet, LJ van Loon
Acta Diabetologica 2009
Hepatic triacylglycerol accumulation and insulin resistance
CA Nagle, EL Klett, RA Coleman
Journal of lipid research 2009
A negative regulatory pathway of GLUT4 trafficking in adipocyte: new function of RIP140 in the cytoplasm via AS160
PC Ho, YW Lin, YC Tsui, P Gupta, LN Wei
Cell Metabolism 2009
Deletion of PKC  Selectively Enhances the Amplifying Pathways of Glucose-Stimulated Insulin Secretion via Increased Lipolysis in Mouse  -Cells
J Cantley, JG Burchfield, GL Pearson, C Schmitz-Peiffer, M Leitges, TJ Biden
Diabetes 2009
Olive oil consumption and non-alcoholic fatty liver disease
N Assy, F Nassar, G Nasser, M Grosovski
World journal of gastroenterology : WJG 2009
Insulin resistance due to lipid-induced signaling defects could be prevented by mahanine
A Biswas, S Bhattacharya, S Dasgupta, R Kundu, SS Roy, BC Pal, S Bhattacharya
Molecular and Cellular Biochemistry 2009
Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene
K Kantartzis, A Peter, F Machicao, J Machann, S Wagner, I Königsrainer, A Königsrainer, F Schick, A Fritsche, HU Häring, N Stefan
Diabetes 2009
Elovl6: a new player in fatty acid metabolism and insulin sensitivity
T Matsuzaka, H Shimano
Journal of Molecular Medicine 2009
D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression
C Zeng, Y Han, H Huang, C Yu, H Ren, W Shi, D He, L Huang, C Yang, X Wang, L Zhou, PA Jose
Journal of Hypertension 2009
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice
Catherine Postic*1,2 and Jean Girard1,2
Journal of Clinical Investigation 2008
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia
H Doege, D Grimm, A Falcon, B Tsang, TA Storm, H Xu, AM Ortegon, M Kazantzis, MA Kay, A Stahl
The Journal of biological chemistry 2008
PKCepsilon plays a causal role in acute ethanol-induced steatosis
JP Kaiser, JI Beier, J Zhang, JD Hoetker, C Montfort, L Guo, Y Zheng, BP Monia, A Bhatnagar, GE Arteel
Archives of Biochemistry and Biophysics 2008
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis
JJ Maher, P Leon, JC Ryan
Hepatology 2008
Inflammatory Mechanisms in the Regulation of Insulin Resistance
H Tilg, AR Moschen
Molecular Medicine 2008
Protein Kinase C Function in Muscle, Liver, and  -Cells and Its Therapeutic Implications for Type 2 Diabetes
C Schmitz-Peiffer, TJ Biden
Diabetes 2008
Pck1 Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in db/db Mice
AG Gomez-Valades, A Mendez-Lucas, A Vidal-Alabro, FX Blasco, M Chillon, R Bartrons, J Bermudez, JC Perales
Diabetes 2008
Inhibition of ADRP prevents diet-induced insulin resistance
GM Varela, DA Antwi, R Dhir, X Yin, NS Singhal, MJ Graham, RM Crooke, RS Ahima
American journal of physiology. Gastrointestinal and liver physiology 2008
Ectopic fat and insulin resistance
A Lettner, M Roden
Current Diabetes Reports 2008
Mechanism by Which Overexpression of Uncoupling Protein 3 in Skeletal Muscle Protects Against Fat-Induced Insulin Resistance
Cheol Soo Choi, Jonathan J. Fillmore, Jason K. Kim, Zhen-Xiang Liu, Sheene Kim, Emily F. Collier, Ameya Kulkarni, Alberto Distefano, Yu-Jin Hwang, Mario Kahn, Yan Chen, Chunli Yu, Irene K. Moore, Richard M. Reznick, Takamasa Higashimori, Gerald I. Shulman
Journal of Clinical Investigation 2007
Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance
D Zhang, ZX Liu, CS Choi, L Tian, R Kibbey, J Dong, GW Cline, PA Wood, GI Shulman
Proceedings of the National Academy of Sciences 2007
Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance
CA Nagle, J An, M Shiota, TP Torres, GW Cline, ZX Liu, S Wang, RL Catlin, GI Shulman, CB Newgard, RA Coleman
The Journal of biological chemistry 2007
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
KF Petersen, S Dufour, DB Savage, S Bilz, G Solomon, S Yonemitsu, GW Cline, D Befroy, L Zemany, BB Kahn, X Papademetris, DL Rothman, GI Shulman
Proceedings of the National Academy of Sciences 2007
Benefits of lifestyle modification in NAFLD
SA Harrison, CP Day
Gut 2007
Continuous fat oxidation in acetyl CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity
CS Choi, DB Savage, L Abu-Elheiga, ZX Liu, S Kim, A Kulkarni, A Distefano, YJ Hwang, RM Reznick, R Codella, D Zhang, GW Cline, SJ Wakil, GI Shulman
Proceedings of the National Academy of Sciences 2007
Metabolic stress signaling mediated by mixed-lineage kinases
A Jaeschke, RJ Davis
Molecular Cell 2007
Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance
M Adiels, J Westerbacka, A Soro-Paavonen, AM Häkkinen, S Vehkavaara, MJ Caslake, C Packard, SO Olofsson, H Yki-Järvinen, MR Taskinen, J Borén
Diabetologia 2007

← Previous 1 2 3 … 10 11 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 patents
Highlighted by 1 platforms
227 readers on Mendeley
See more details